Hydrochloric Acid

Hydrochloric Acid

SCHEMBL6389088

COc1ccc(Nc2ccc(N)cc2)cc1.Cl

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA known ✓ P10253 6/20 0.74
▸ CA2 known ✓ P00918 1/20 0.48
▸ KCNH3 known ✓ Q9ULD8 1/20 0.47
▸ NR4A1 P22736 1/20 0.96
▸ MAPT P10636 7/20 0.74
▸ ALDH1A1 P00352 6/20 0.74
▸ TDP1 Q9NUW8 4/20 0.74
▸ RAB9A P51151 4/20 0.74
▸ L3MBTL1 Q9Y468 4/20 0.74
▸ MAPK1 P28482 3/20 0.74
▸ KDM4E B2RXH2 2/20 0.74
▸ THRB P10828 2/20 0.74
▸ RECQL P46063 2/20 0.74
▸ CYP3A4 P08684 2/20 0.74
▸ NPC1 O15118 1/20 0.74
▸ NPSR1 Q6W5P4 1/20 0.74
▸ HTT P42858 3/20 0.59
▸ MEN1 O00255 3/20 0.59
▸ KMT2A Q03164 3/20 0.59
▸ MMP14 P50281 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1618639 0.98 NR4A1 (1.00) NR4A1MAPTALDH1A1GAATDP1
SCHEMBL27956260 0.92 NR4A1 (0.88) NR4A1MAPTALDH1A1GAATDP1
SCHEMBL11764736 0.90 NR4A1 (0.85) NR4A1MAPTALDH1A1GAATDP1
SCHEMBL30511913 0.87 NR4A1 (0.79) NR4A1MAPTALDH1A1GAATDP1
Sulfuric Acid SCHEMBL29722524 0.87 NR4A1 (0.79) NR4A1MAPTALDH1A1GAATDP1
Sulfuric Acid SCHEMBL11419340 0.87 NR4A1 (0.79) NR4A1MAPTALDH1A1GAATDP1
SCHEMBL1459772 0.86 MAPT (1.00) NR4A1MAPTALDH1A1GAATDP1
SCHEMBL39057 0.86 MAPT (1.00) NR4A1MAPTALDH1A1GAATDP1
Hydrochloric Acid SCHEMBL4376059 0.86 ALDH1A1 (1.00) NR4A1MAPTALDH1A1TDP1RAB9A
Hydrochloric Acid SCHEMBL208637 0.86 ALDH1A1 (1.00) NR4A1MAPTALDH1A1TDP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4511649-B1 METHOD AND KIT FOR THE DETECTION OF CHROMIUM-6 IN A SAMPLE SEEF B V (NL) 2026-03-11 — — EP claimed
EP-4511649-A1 METHOD FOR THE DETECTION OF CHROMIUM-6 IN A SAMPLE SEEF B.V. (NL) 2025-02-26 — — EP claimed
WO-2023219493-A1 METHOD FOR THE DETECTION OF CHROMIUM-6 IN A SAMPLE SEEF B.V. (NL) 2023-11-16 — — WO claimed
JP-60181653-A — — None — — JP disclosed
EP-4511649-B1 METHOD AND KIT FOR THE DETECTION OF CHROMIUM-6 IN A SAMPLE SEEF B V (NL) 2026-03-11 — — EP disclosed
US-20250314593-A1 DEVICES, METHODS AND KITS FOR DETECTING EXPLOSIVES AND ILLICIT DRUG SUBSTANCES TRACE EYE-D, LLC 2025-10-09 — — US disclosed
EP-4511649-A1 METHOD FOR THE DETECTION OF CHROMIUM-6 IN A SAMPLE SEEF B.V. (NL) 2025-02-26 — — EP disclosed
WO-2023219493-A1 METHOD FOR THE DETECTION OF CHROMIUM-6 IN A SAMPLE SEEF B.V. (NL) 2023-11-16 — — WO disclosed
WO-2023150396-A1 DEVICES, METHODS AND KITS FOR DETECTING EXPLOSIVES AND ILLICIT DRUG SUBSTANCES TRACE EYE-D, LLC (US) 2023-08-10 — — WO disclosed
US-20050042674-A9 Common ligand mimics: thiazolidinediones and rhodanines TRIAD THERAPEUTICS, INC. 2005-02-24 — — US disclosed
EP-0884367-B1 Light-writable data storage media containing cationic diphenylamine dyes BAYER AG (DE) 2003-08-13 — — EP disclosed
US-5952475-A CATIONIC THIADIAZOLEDIPHENYLAMINE DYES FOR USE IN INKJET PRINTING AND IN LIGHT-WRITABLE DATA STORAGE MEDIA AND IN DYE TRANSFER FILMS BAYER AKTIENGESELLSCHAFT (DE) 1999-09-14 — — US disclosed
US-5790627-A Method and apparatus for observing a specimen using an X-ray microscope RESEARCH DEVELOPMENT CORP. (JP) 1998-08-04 — — US disclosed
EP-0567207-B1 Method of reducing impurities in aqueous monomer solutions ROHM & HAAS (US) 1997-08-06 — — EP disclosed
EP-0763512-A1 AIR BAG GAS GENERATING AGENT OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 1997-03-19 — — EP disclosed
WO-1995011001-A1 1,3-PROPANDIONES FOR DYEING KERATINIC FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1995-04-27 — — WO disclosed
EP-0567207-A2 Method of reducing impurities in aqueous monomer solutions ROHM AND HAAS COMPANY (US) 1993-10-27 — — EP disclosed
US-5208370-A Reducing protoanemonin by using phenylenediamines ROHM AND HAAS CO. (US) 1993-05-04 — — US disclosed
JP-S60181653-A OXYGEN DETECTOR DAINIPPON PRINTING CO LTD 1985-09-17 — — JP disclosed
US-4042329-A Method and device for detecting cholesterol BECTON, DICKINSON AND COMPANY (US) 1977-08-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050042674-A9 Common ligand mimics: thiazolidinediones and rhodanines GPR65, NR2E3, FGFR3 GAA 2005/4885CA2 1275/4885KCNH3 2998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback